S&P 500   2,663.68 (+7.03%)
DOW   22,679.99 (+7.73%)
QQQ   196.48 (+7.15%)
AAPL   262.47 (+8.72%)
FB   165.55 (+7.37%)
MSFT   165.33 (+7.48%)
GOOGL   1,183.19 (+8.28%)
AMZN   1,997.59 (+4.77%)
CGC   14.34 (+8.23%)
NVDA   268.40 (+10.04%)
BABA   196.45 (+4.99%)
MU   46.37 (+12.49%)
GE   7.23 (+7.43%)
TSLA   516.24 (+7.55%)
AMD   47.52 (+11.58%)
T   29.44 (+7.21%)
ACB   0.80 (-1.24%)
F   4.53 (+6.84%)
NFLX   379.96 (+5.03%)
BAC   21.39 (+6.79%)
GILD   77.73 (-0.61%)
DIS   99.58 (+6.07%)
PRI   87.09 (+7.93%)
S&P 500   2,663.68 (+7.03%)
DOW   22,679.99 (+7.73%)
QQQ   196.48 (+7.15%)
AAPL   262.47 (+8.72%)
FB   165.55 (+7.37%)
MSFT   165.33 (+7.48%)
GOOGL   1,183.19 (+8.28%)
AMZN   1,997.59 (+4.77%)
CGC   14.34 (+8.23%)
NVDA   268.40 (+10.04%)
BABA   196.45 (+4.99%)
MU   46.37 (+12.49%)
GE   7.23 (+7.43%)
TSLA   516.24 (+7.55%)
AMD   47.52 (+11.58%)
T   29.44 (+7.21%)
ACB   0.80 (-1.24%)
F   4.53 (+6.84%)
NFLX   379.96 (+5.03%)
BAC   21.39 (+6.79%)
GILD   77.73 (-0.61%)
DIS   99.58 (+6.07%)
PRI   87.09 (+7.93%)
S&P 500   2,663.68 (+7.03%)
DOW   22,679.99 (+7.73%)
QQQ   196.48 (+7.15%)
AAPL   262.47 (+8.72%)
FB   165.55 (+7.37%)
MSFT   165.33 (+7.48%)
GOOGL   1,183.19 (+8.28%)
AMZN   1,997.59 (+4.77%)
CGC   14.34 (+8.23%)
NVDA   268.40 (+10.04%)
BABA   196.45 (+4.99%)
MU   46.37 (+12.49%)
GE   7.23 (+7.43%)
TSLA   516.24 (+7.55%)
AMD   47.52 (+11.58%)
T   29.44 (+7.21%)
ACB   0.80 (-1.24%)
F   4.53 (+6.84%)
NFLX   379.96 (+5.03%)
BAC   21.39 (+6.79%)
GILD   77.73 (-0.61%)
DIS   99.58 (+6.07%)
PRI   87.09 (+7.93%)
S&P 500   2,663.68 (+7.03%)
DOW   22,679.99 (+7.73%)
QQQ   196.48 (+7.15%)
AAPL   262.47 (+8.72%)
FB   165.55 (+7.37%)
MSFT   165.33 (+7.48%)
GOOGL   1,183.19 (+8.28%)
AMZN   1,997.59 (+4.77%)
CGC   14.34 (+8.23%)
NVDA   268.40 (+10.04%)
BABA   196.45 (+4.99%)
MU   46.37 (+12.49%)
GE   7.23 (+7.43%)
TSLA   516.24 (+7.55%)
AMD   47.52 (+11.58%)
T   29.44 (+7.21%)
ACB   0.80 (-1.24%)
F   4.53 (+6.84%)
NFLX   379.96 (+5.03%)
BAC   21.39 (+6.79%)
GILD   77.73 (-0.61%)
DIS   99.58 (+6.07%)
PRI   87.09 (+7.93%)
Log in

NASDAQ:CMRXChimerix News Headlines

$1.40
+0.07 (+5.26 %)
(As of 04/6/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.34
Now: $1.40
$1.44
50-Day Range
$1.27
MA: $1.56
$2.00
52-Week Range
$1.19
Now: $1.40
$4.40
Volume270,416 shs
Average Volume447,579 shs
Market Capitalization$86.44 million
P/E RatioN/A
Dividend YieldN/A
Beta1.28

Headlines

Chimerix (NASDAQ CMRX) News Headlines

Source:
DateHeadline
Chimerix Inc (NASDAQ:CMRX) Short Interest UpdateChimerix Inc (NASDAQ:CMRX) Short Interest Update
www.americanbankingnews.com - March 28 at 4:30 AM
Chimerix (CMRX) Chief Medical Officer Garrett Nichols to Resign - StreetInsider.comChimerix (CMRX) Chief Medical Officer Garrett Nichols to Resign - StreetInsider.com
www.streetinsider.com - March 24 at 6:19 PM
Chimerix (CMRX) Presents At Cowen and Companys 40th Annual Health Care Conference - SlideshowChimerix (CMRX) Presents At Cowen and Company's 40th Annual Health Care Conference - Slideshow
seekingalpha.com - March 21 at 6:37 AM
Michael Sherman Is The CEO, President & Director of Chimerix, Inc. (NASDAQ:CMRX) And They Just Spent US$106k On Shares - Yahoo FinanceMichael Sherman Is The CEO, President & Director of Chimerix, Inc. (NASDAQ:CMRX) And They Just Spent US$106k On Shares - Yahoo Finance
finance.yahoo.com - March 19 at 8:23 AM
Michael Sherman Is The CEO, President & Director of Chimerix, Inc. (NASDAQ:CMRX) And They Just Spent US$106k On SharesMichael Sherman Is The CEO, President & Director of Chimerix, Inc. (NASDAQ:CMRX) And They Just Spent US$106k On Shares
finance.yahoo.com - March 18 at 8:52 AM
Insider Buying: Chimerix Inc (NASDAQ:CMRX) Insider Purchases 33,300 Shares of StockInsider Buying: Chimerix Inc (NASDAQ:CMRX) Insider Purchases 33,300 Shares of Stock
www.americanbankingnews.com - March 17 at 4:59 PM
Insider Buying: Chimerix Inc (NASDAQ:CMRX) Director Acquires 50,000 Shares of StockInsider Buying: Chimerix Inc (NASDAQ:CMRX) Director Acquires 50,000 Shares of Stock
www.americanbankingnews.com - March 16 at 5:36 PM
Chimerix Inc (NASDAQ:CMRX) CEO Michael A. Sherman Buys 72,995 SharesChimerix Inc (NASDAQ:CMRX) CEO Michael A. Sherman Buys 72,995 Shares
www.americanbankingnews.com - March 16 at 4:38 PM
Edited Transcript of CMRX earnings conference call or presentation 25-Feb-20 1:30pm GMT - Yahoo FinanceEdited Transcript of CMRX earnings conference call or presentation 25-Feb-20 1:30pm GMT - Yahoo Finance
finance.yahoo.com - March 5 at 8:51 AM
Edited Transcript of CMRX earnings conference call or presentation 25-Feb-20 1:30pm GMTEdited Transcript of CMRX earnings conference call or presentation 25-Feb-20 1:30pm GMT
finance.yahoo.com - March 5 at 8:51 AM
All You Need to Know About Chimerix (CMRX) Rating Upgrade to Buy - Yahoo FinanceAll You Need to Know About Chimerix (CMRX) Rating Upgrade to Buy - Yahoo Finance
finance.yahoo.com - February 28 at 1:05 PM
All You Need to Know About Chimerix (CMRX) Rating Upgrade to BuyAll You Need to Know About Chimerix (CMRX) Rating Upgrade to Buy
finance.yahoo.com - February 28 at 1:05 PM
Chimerix to Present at Cowen and Company 40th Annual Health Care Conference - StreetInsider.comChimerix to Present at Cowen and Company 40th Annual Health Care Conference - StreetInsider.com
www.streetinsider.com - February 27 at 9:05 AM
Chimerix to Present at Cowen and Company 40th Annual Health Care Conference - Yahoo FinanceChimerix to Present at Cowen and Company 40th Annual Health Care Conference - Yahoo Finance
finance.yahoo.com - February 26 at 1:06 PM
Chimerix to Present at Cowen and Company 40th Annual Health Care ConferenceChimerix to Present at Cowen and Company 40th Annual Health Care Conference
finance.yahoo.com - February 26 at 1:05 PM
Chimerix +13% on Q4 beat - Seeking AlphaChimerix +13% on Q4 beat - Seeking Alpha
seekingalpha.com - February 25 at 2:08 PM
Chimerix Reports Fourth Quarter and Year End 2019 Financial Results and Provides Operational Update - Yahoo FinanceChimerix Reports Fourth Quarter and Year End 2019 Financial Results and Provides Operational Update - Yahoo Finance
finance.yahoo.com - February 25 at 2:08 PM
Chimerix Reports Fourth Quarter and Year End 2019 Financial Results and Provides Operational Update - BenzingaChimerix Reports Fourth Quarter and Year End 2019 Financial Results and Provides Operational Update - Benzinga
www.benzinga.com - February 25 at 9:07 AM
Form 10-K CHIMERIX INC For: Dec 31 - StreetInsider.comForm 10-K CHIMERIX INC For: Dec 31 - StreetInsider.com
www.streetinsider.com - February 25 at 9:07 AM
Form 8-K CHIMERIX INC For: Feb 25 - StreetInsider.comForm 8-K CHIMERIX INC For: Feb 25 - StreetInsider.com
www.streetinsider.com - February 25 at 9:07 AM
Chimerix, Inc. to Host Earnings CallChimerix, Inc. to Host Earnings Call
finance.yahoo.com - February 25 at 9:07 AM
Chimerix Reports Fourth Quarter and Year End 2019 Financial Results and Provides Operational UpdateChimerix Reports Fourth Quarter and Year End 2019 Financial Results and Provides Operational Update
finance.yahoo.com - February 25 at 9:07 AM
Chimerix Appoints Pratik S. Multani, M.D., to Board of Directors - Yahoo FinanceChimerix Appoints Pratik S. Multani, M.D., to Board of Directors - Yahoo Finance
finance.yahoo.com - February 24 at 9:05 AM
Chimerix (CMRX) Announces Pratik S. Multani, MD to Board - StreetInsider.comChimerix (CMRX) Announces Pratik S. Multani, MD to Board - StreetInsider.com
www.streetinsider.com - February 24 at 9:05 AM
Chimerix Appoints Pratik S. Multani, M.D., to Board of DirectorsChimerix Appoints Pratik S. Multani, M.D., to Board of Directors
finance.yahoo.com - February 24 at 9:05 AM
Chimerix to Report Fourth Quarter and Year End 2019 Financial Results and Provide an Operational Update on February 25, 2020 - GlobeNewswireChimerix to Report Fourth Quarter and Year End 2019 Financial Results and Provide an Operational Update on February 25, 2020 - GlobeNewswire
www.globenewswire.com - February 19 at 8:48 AM
Chimerix to Report Fourth Quarter and Year End 2019 Financial Results and Provide an Operational Update on February 25, 2020 - Yahoo FinanceChimerix to Report Fourth Quarter and Year End 2019 Financial Results and Provide an Operational Update on February 25, 2020 - Yahoo Finance
finance.yahoo.com - February 18 at 12:32 PM
Chimerix to Report Fourth Quarter and Year End 2019 Financial Results and Provide an Operational Update on February 25, 2020Chimerix to Report Fourth Quarter and Year End 2019 Financial Results and Provide an Operational Update on February 25, 2020
finance.yahoo.com - February 18 at 12:32 PM
Investors Who Bought Chimerix (NASDAQ:CMRX) Shares Five Years Ago Are Now Down 96% - Yahoo FinanceInvestors Who Bought Chimerix (NASDAQ:CMRX) Shares Five Years Ago Are Now Down 96% - Yahoo Finance
finance.yahoo.com - February 6 at 12:20 PM
Investors Who Bought Chimerix (NASDAQ:CMRX) Shares Five Years Ago Are Now Down 96%Investors Who Bought Chimerix (NASDAQ:CMRX) Shares Five Years Ago Are Now Down 96%
finance.yahoo.com - February 6 at 7:18 AM
Chimerix up 10% premarket on potential of brincidofovir in smallpox - Seeking AlphaChimerix up 10% premarket on potential of brincidofovir in smallpox - Seeking Alpha
seekingalpha.com - January 30 at 9:35 AM
Chimerix Presents Data Supporting Brincidofovir as a Potential Treatment for Smallpox at 2020 American Society for Microbiology Biothreats Meeting - Yahoo FinanceChimerix Presents Data Supporting Brincidofovir as a Potential Treatment for Smallpox at 2020 American Society for Microbiology Biothreats Meeting - Yahoo Finance
finance.yahoo.com - January 29 at 12:43 PM
Chimerix Presents Data Supporting Brincidofovir as a Potential Treatment for Smallpox at 2020 American Society for Microbiology Biothreats MeetingChimerix Presents Data Supporting Brincidofovir as a Potential Treatment for Smallpox at 2020 American Society for Microbiology Biothreats Meeting
finance.yahoo.com - January 29 at 12:43 PM
Chimerix IncChimerix Inc
www.bloomberg.com - January 23 at 4:46 AM
Has Chimerix (CMRX) Outpaced Other Medical Stocks This Year? - Yahoo FinanceHas Chimerix (CMRX) Outpaced Other Medical Stocks This Year? - Yahoo Finance
finance.yahoo.com - January 3 at 3:48 PM
Has Chimerix (CMRX) Outpaced Other Medical Stocks This Year?Has Chimerix (CMRX) Outpaced Other Medical Stocks This Year?
finance.yahoo.com - January 3 at 3:48 PM
Heres Why Were Watching Chimerixs (NASDAQ:CMRX) Cash Burn Situation - Yahoo FinanceHere's Why We're Watching Chimerix's (NASDAQ:CMRX) Cash Burn Situation - Yahoo Finance
finance.yahoo.com - December 23 at 8:28 AM
Here's Why We're Watching Chimerix's (NASDAQ:CMRX) Cash Burn SituationHere's Why We're Watching Chimerix's (NASDAQ:CMRX) Cash Burn Situation
finance.yahoo.com - December 23 at 8:28 AM
Is Chimerix Inc (CMRX) A Good Stock To Buy? - Yahoo FinanceIs Chimerix Inc (CMRX) A Good Stock To Buy? - Yahoo Finance
finance.yahoo.com - December 14 at 11:25 PM
Is Chimerix Inc (CMRX) A Good Stock To Buy?Is Chimerix Inc (CMRX) A Good Stock To Buy?
finance.yahoo.com - December 14 at 11:25 PM
Chimerix Presents Updated Results from Phase 2 Clinical Trial of DSTAT in Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia at American Society of Hematology Annual Meeting - StreetInsider.comChimerix Presents Updated Results from Phase 2 Clinical Trial of DSTAT in Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia at American Society of Hematology Annual Meeting - StreetInsider.com
www.streetinsider.com - December 12 at 6:46 PM
Chimerix Presents Updated Results from Phase 2 Clinical Trial of DSTAT in Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia at American Society of Hematology Annual Meeting - Yahoo FinanceChimerix Presents Updated Results from Phase 2 Clinical Trial of DSTAT in Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia at American Society of Hematology Annual Meeting - Yahoo Finance
finance.yahoo.com - December 12 at 8:45 AM
Chimerix down 21% despite positive DSTAT data in MDS and AML - Seeking AlphaChimerix down 21% despite positive DSTAT data in MDS and AML - Seeking Alpha
seekingalpha.com - December 10 at 2:40 PM
Chimerix Presents Updated Results from Phase 2 Clinical Trial of DSTAT in Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia at American Society of Hematology Annual Meeting - GlobeNewswireChimerix Presents Updated Results from Phase 2 Clinical Trial of DSTAT in Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia at American Society of Hematology Annual Meeting - GlobeNewswire
www.globenewswire.com - December 10 at 9:39 AM
Chimerix Presents Updated Results from Phase 2 Clinical Trial of DSTAT in Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia at American Society of Hematology Annual MeetingChimerix Presents Updated Results from Phase 2 Clinical Trial of DSTAT in Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia at American Society of Hematology Annual Meeting
finance.yahoo.com - December 10 at 9:39 AM
Edited Transcript of CMRX earnings conference call or presentation 5-Nov-19 1:30pm GMT - Yahoo FinanceEdited Transcript of CMRX earnings conference call or presentation 5-Nov-19 1:30pm GMT - Yahoo Finance
finance.yahoo.com - November 11 at 10:55 PM
Edited Transcript of CMRX earnings conference call or presentation 5-Nov-19 1:30pm GMTEdited Transcript of CMRX earnings conference call or presentation 5-Nov-19 1:30pm GMT
finance.yahoo.com - November 11 at 10:54 PM
Should You Be Concerned About Chimerix, Inc.s (NASDAQ:CMRX) Historical Volatility? - Yahoo FinanceShould You Be Concerned About Chimerix, Inc.'s (NASDAQ:CMRX) Historical Volatility? - Yahoo Finance
finance.yahoo.com - November 7 at 7:34 AM
Should You Be Concerned About Chimerix, Inc.'s (NASDAQ:CMRX) Historical Volatility?Should You Be Concerned About Chimerix, Inc.'s (NASDAQ:CMRX) Historical Volatility?
finance.yahoo.com - November 7 at 7:34 AM
Form 10-Q CHIMERIX INC For: Sep 30 - StreetInsider.comForm 10-Q CHIMERIX INC For: Sep 30 - StreetInsider.com
www.streetinsider.com - November 5 at 6:04 PM
This page was last updated on 4/6/2020 by MarketBeat.com Staff

Featured Article: Inverted Yield Curve

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel